Exploring chemical space for “druglike” small molecules in the age of AI

The announcement of 2024 Nobel Prize in Chemistry to Alphafold has reiterated the role of AI in biology and mainly in the domain of “drug discovery”. Till few years ago, structure-based drug design (SBDD) has been the preferred experimental design in many academic and pharmaceutical R and D division...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Aman Achuthan Kattuparambil, Dheeraj Kumar Chaurasia, Shashank Shekhar, Ashwin Srinivasan, Sukanta Mondal, Raviprasad Aduri, B. Jayaram
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2025-03-01
סדרה:	Frontiers in Molecular Biosciences
נושאים:	machine learning (ML) artificial intelligence computer aided drug design (CADD) small molecules BIMP
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fmolb.2025.1553667/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!